Experimental injection may one day reduce need for mastectomies

01/1/2014 | MedicalDaily.com

Harvard University researchers were able to block HoxA1, a specific gene strongly associated with breast cancer, when they injected mice with an RNA agent. The treatment could potentially block the effects of genes that predispose women to certain breast cancers and reduce or eliminate the need for such invasive treatments as mastectomies. The findings appeared in the journal Science Translational Medicine.

View Full Article in:

MedicalDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ